文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAPYes-associated proteinYAP (Yes-associated protein) is a transcription co-activator in the Hippo tumor suppressor pathway and controls cell growth, tissuehomeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to ind
2、uce its cytoplasmic localizationand proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors.The function of YAP in human cancer is complex and could be cell-type-dependent. For instance, YAP could function as a tumorsuppressor in some cell types, such
3、 as hematological cancers, by inducing apoptosis in response to DNA damage.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAP HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERL
4、INK https:/www.MedChemE/Targets/YAP.html Antagonists, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Activators HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html & HYPERLINK https:/www.MedChemE/Targets/YAP.htm
5、l HYPERLINK https:/www.MedChemE/Targets/YAP.html Modulators HYPERLINK https:/www.MedChemE/AICAR.html AICAR(Acadesine; AICA Riboside) Cat. No.: HY-13417 HYPERLINK https:/www.MedChemE/AICAR-phosphate.html AICAR HYPERLINK https:/www.MedChemE/AICAR-phosphate.html HYPERLINK https:/www.MedChemE/AICAR-phos
6、phate.html phosphate(Acadesine phosphate; AICA Riboside phosphate) Cat. No.: HY-13417AAICAR (Acadesine) is an adenosine analog and aAMPK activator. AICAR regulates the glucose andlipid metabolism, and inhibits proinflammatorycytokines and iNOS production. AICAR is also anautophagy, YAP and mitophagy
7、 inhibitor.AICAR phosphate (Acadesine phosphate) is anadenosine analog and a AMPK activator. AICARphosphate regulates the glucose and lipidmetabolism, and inhibits proinflammatory cytokinesand iNOS production. AICAR phosphate is also anautophagy, YAP and mitophagy inhibitor.Purity: 99.92%Clinical Da
8、ta: Phase 3Size: 50 mg, 100 mg, 200 mg, 500 mgPurity: 99.49%Clinical Data: Phase 3Size: 10 mM 1 mL, 50 mg, 100 mg, 200 mg, 500 mg HYPERLINK https:/www.MedChemE/cytochalasin-d.html Cytochalasin HYPERLINK https:/www.MedChemE/cytochalasin-d.html HYPERLINK https:/www.MedChemE/cytochalasin-d.html D(Zygos
9、porin A; NSC 209835) Cat. No.: HY-N6682 HYPERLINK https:/www.MedChemE/k-975.html K-975Cat. No.: HY-138565Cytochalasin D (Zygosporin A; NSC 209835) is apotent and cell-permeable inhibitor of actinpolymerization derived from fungus, inhibits theG-actincofilin interaction by binding to G-actin.K-975 is
10、 a potent, selective and orally activeTEAD inhibitor, with a strong inhibitory effectagainst protein-protein interactions betweenYAP1/TAZ and TEAD. K-975 covalently binds toCys359 located in the palmitate-binding pocket ofTEAD via an acrylamide structure.Purity: 99.75%Clinical Data: No Development R
11、eportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 98.55%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/lats-in-1.html Lats-IN-1 HYPERLINK https:/www.MedChemE/lats-in-1.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html ML-7 HYPERLI
12、NK https:/www.MedChemE/ML-7-hydrochloride.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html hydrochlorideCat. No.: HY-138489 Cat. No.: HY-15417Lats-IN-1 is a potent and ATP-competitiveinhibitor of Lats1 and Lats2 kinases. Lats-IN-1promotes Yap-dependent proliferation inpostmitotic mammalian
13、 tissues.ML-7 hydrochloride is a naphthalene sulphonamidederivative, potently inhibits MLCK (IC =30050nM). ML-7 hydrochloride also inhibits YAP/TAZ.Purity: 99.98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.75%Clinical Data: No Development ReportedSize: 10
14、mM 1 mL, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/myf-01-37.html MYF-01-37 HYPERLINK https:/www.MedChemE/myf-01-37.html HYPERLINK https:/www.MedChemE/py-60.html PY-60Cat. No.: HY-139603 Cat. No.: HY-141644MYF-01-37 is a covalent TEAD inhibitor targetingCys380. MYF-01-37 has a reversible inhibition
15、 onYAP/TEAD interaction.PY-60 is a robust and specific activator of YAPtranscriptional activity that targets annexin A2(ANXA2) with a K of 1.4 M. PY-60 directlydbinds to ANXA2 and antagonizes its normal cellularfunction of repressing YAP activity.Purity: 98.98%Clinical Data: No Development ReportedS
16、ize: 5 mg, 10 mg, 50 mg, 100 mgPurity: 98.63%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/super-tdu.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html Super-TDU HYPER
17、LINK https:/www.MedChemE/super-tdu-1-31.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html (1-31)Cat. No.: HY-P1727 Cat. No.: HY-P1728Super-TDU is a specific YAP antagonist targetingYAP-TEADs interaction. Super-TDU suppresses tumorgrowth in gastric cancer mouse model.Super-TDU (1-31) is a peptid
18、e of Super-TDU, whichis an inhibitor of YAP-TEADs, shows potentanti-tumor activity.Purity: 98.85%Clinical Data: No Development ReportedSize: 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/
19、super-tdu-1-31-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (1-31) HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (TFA) HYPERLINK https:/www.MedChemE/super-t
20、du-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html TFACat. No.: HY-P1728A Cat. No.: HY-P1727ASuper-TDU (1-31) is a peptide of Super-TDU, whichis an inhibitor of YAP-TEADs, shows
21、 potentanti-tumor activity.Super-TDU TFA is a specific YAP antagonisttargeting YAP-TEADs interaction. Super-TDU TFAsuppresses tumor growth in gastric cancer mousemodel.Purity: 96.04%Clinical Data: No Development ReportedSize: 1 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPE
22、RLINK https:/www.MedChemE/ted-347.html TED-347Cat. No.: HY-125269 HYPERLINK https:/www.MedChemE/Verteporfin.html Verteporfin(CL 318952) Cat. No.: HY-B0146TED-347 is a potent, irreversible, covalent andallosteric inhibitor at YAP-TEAD protein-proteininteraction with an EC of 5.9 M for TEAD4Yap150prot
23、ein-protein interaction.Verteporfin (CL 318952) is a photosensitizer forphotodynamic therapy to eliminate the abnormalblood vessels in the eye associated withconditions such as age-related maculardegeneration. Verteporfin is a YAP inhibitorwhich disrupts YAP-TEAD interactions.Purity: 98.78%Clinical
24、Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 25 mg, 50 mgPurity: 99.58%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/vt103.html VT103 HYPERLINK https:/www.MedChemE/vt103.html HYPERLINK https:/www.MedChemE/vt107.html VT107Cat. N
25、o.: HY-134955 Cat. No.: HY-134957VT103, an analog of VT101, is an orally active andselective TEAD1 protein palmitoylation inhibitor.VT103 inhibits YAP/TAZ-TEAD promoted genetranscription, blocks TEAD auto-palmitoylation,and disrupts interaction between YAP/TAZ andTEAD.VT-107, as an analogous to VT10
26、4, is an orallyactive and potent pan-TEAD auto-palmitoylationinhibitor. VT-107 can be used for the research ofcancer.Purity: 99.21%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.98%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50
27、 mg, 100 mg HYPERLINK https:/www.MedChemE/yap-tead.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead-tfa.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html TFACat. No.: HY-P2244 Cat. No.: HY-P2244AYAP-TEAD-IN-1 is a potent and competitiveinhibitor of YAPTEAD interaction (IC =2550nM). YAP-TEAD-IN-1 is a 17mer pep
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025重庆市璧山区第二人民医院招聘5人笔试备考重点试题及答案解析
- 2026湖北宜昌市“招才兴业”教育系统事业单位人才引进招聘19人·武汉大学站笔试备考重点题库及答案解析
- 2025年安徽某国有企业后勤人员招聘1人备考考试题库及答案解析
- 2025年福建省老年医院编外合同制人员招聘15人备考题库参考答案详解
- 2025年吉林大学经济学院专业教师招聘5人备考题库(二)及答案详解参考
- 2025年淳安小学语文真题及答案
- 南京市江宁区卫生健康委员会所属部分事业单位2025年公开招聘编制外工作人员备考题库及答案详解1套
- 2025河北石家庄市国有企业招聘21人笔试参考题库附带答案详解(3卷合一版)
- 2025四川南充市总工会遴选参照管理人员2人笔试备考重点试题及答案解析
- 2025汉中市汉台区产业投资发展集团有限公司招聘中层负责人(6人)笔试参考题库附带答案详解(3卷合一版)
- 驻外销售人员管理办法
- 医疗反歧视培训
- 儿童体适能初级基础课程8
- 燃用生物质循环流化床锅炉生产项目节能评估报告(节能专)
- GB/T 45701-2025校园配餐服务企业管理指南
- 2025-2030中国高效节能电机行业竞争力优势与发展行情监测研究报告
- 健身房合伙协议书
- 美甲师聘用合同协议
- 《储能电站技术监督导则》2580
- 保安人员安全知识培训内容
- 垃圾池维修合同范例
评论
0/150
提交评论